IS7528A - Nýir etónógestrel esterar - Google Patents

Nýir etónógestrel esterar

Info

Publication number
IS7528A
IS7528A IS7528A IS7528A IS7528A IS 7528 A IS7528 A IS 7528A IS 7528 A IS7528 A IS 7528A IS 7528 A IS7528 A IS 7528A IS 7528 A IS7528 A IS 7528A
Authority
IS
Iceland
Prior art keywords
new
etonogestrel esters
esters
new etonogestrel
etonogestrel
Prior art date
Application number
IS7528A
Other languages
English (en)
Other versions
IS2421B (is
Inventor
De Nijs Henrik
Adrianus Antonius Van Der Voort Hendrikus
Leysen Dirk
Jan Grootenhuis Arij
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of IS7528A publication Critical patent/IS7528A/is
Publication of IS2421B publication Critical patent/IS2421B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS7528A 2002-05-30 2004-11-15 Nýir etónógestrel esterar IS2421B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02077119 2002-05-30
PCT/EP2003/050187 WO2003102012A2 (en) 2002-05-30 2003-05-22 New etonogestrel esters

Publications (2)

Publication Number Publication Date
IS7528A true IS7528A (is) 2004-11-15
IS2421B IS2421B (is) 2008-10-15

Family

ID=29595014

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7528A IS2421B (is) 2002-05-30 2004-11-15 Nýir etónógestrel esterar

Country Status (30)

Country Link
US (1) US7323454B2 (is)
EP (1) EP1513861B1 (is)
JP (1) JP4716726B2 (is)
KR (1) KR20050009723A (is)
CN (2) CN1314701C (is)
AR (1) AR040130A1 (is)
AT (1) ATE349458T1 (is)
AU (1) AU2003238081B2 (is)
BR (1) BR0311254A (is)
CA (1) CA2487722C (is)
CO (1) CO5631449A2 (is)
DE (1) DE60310714T2 (is)
DK (1) DK1513861T3 (is)
ES (1) ES2277085T3 (is)
HR (1) HRP20041101A2 (is)
IL (1) IL165087A0 (is)
IS (1) IS2421B (is)
MX (1) MXPA04011797A (is)
NO (1) NO20044898L (is)
NZ (1) NZ536619A (is)
PE (1) PE20040068A1 (is)
PL (1) PL373855A1 (is)
PT (1) PT1513861E (is)
RS (1) RS97604A (is)
RU (1) RU2325910C2 (is)
SI (1) SI1513861T1 (is)
TW (1) TW200403065A (is)
UA (1) UA80126C2 (is)
WO (1) WO2003102012A2 (is)
ZA (1) ZA200410410B (is)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200400041A (en) * 2002-05-30 2004-01-01 Akzo Nobel Nv Use of new etonogestrel esters
WO2007011707A2 (en) 2005-07-15 2007-01-25 Micell Technologies, Inc. Polymer coatings containing drug powder of controlled morphology
WO2007011708A2 (en) 2005-07-15 2007-01-25 Micell Technologies, Inc. Stent with polymer coating containing amorphous rapamycin
ES2540059T3 (es) 2006-04-26 2015-07-08 Micell Technologies, Inc. Recubrimientos que contienen múltiples fármacos
CA2679712C (en) 2007-01-08 2016-11-15 Micell Technologies, Inc. Stents having biodegradable layers
US11426494B2 (en) 2007-01-08 2022-08-30 MT Acquisition Holdings LLC Stents having biodegradable layers
US9433516B2 (en) 2007-04-17 2016-09-06 Micell Technologies, Inc. Stents having controlled elution
MX2010011485A (es) 2008-04-17 2011-03-01 Micell Technologies Inc Stents que contienen capas bioadsorbibles.
US9510856B2 (en) 2008-07-17 2016-12-06 Micell Technologies, Inc. Drug delivery medical device
WO2010009335A1 (en) 2008-07-17 2010-01-21 Micell Technologies, Inc. Drug delivery medical device
WO2010111232A2 (en) 2009-03-23 2010-09-30 Micell Technologies, Inc. Drug delivery medical device
WO2010120552A2 (en) 2009-04-01 2010-10-21 Micell Technologies, Inc. Coated stents
WO2011097103A1 (en) 2010-02-02 2011-08-11 Micell Technologies, Inc. Stent and stent delivery system with improved deliverability
US10232092B2 (en) 2010-04-22 2019-03-19 Micell Technologies, Inc. Stents and other devices having extracellular matrix coating
EP2593039B1 (en) 2010-07-16 2022-11-30 Micell Technologies, Inc. Drug delivery medical device
CA2841360A1 (en) 2011-07-15 2013-01-24 Micell Technologies, Inc. Drug delivery medical device
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
CN105307597A (zh) 2013-03-12 2016-02-03 脉胜医疗技术公司 可生物吸收的生物医学植入物
US10272606B2 (en) 2013-05-15 2019-04-30 Micell Technologies, Inc. Bioabsorbable biomedical implants
RU2595818C1 (ru) * 2015-05-25 2016-08-27 Федеральное государственное бюджетное научное учреждение "Научный центр проблем здоровья семьи и репродукции человека" Способ комплексного лечения дисфункции яичников при применении гормонального контрацептива имплантата "импланона"
CN111057120B (zh) * 2019-12-27 2021-04-27 苏州翔实医药发展有限公司 一种依托孕烯衍生物a及其制备方法和用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB845442A (en) 1956-03-22 1960-08-24 Schering Ag Manufacture of steroid compounds
DE1013284B (de) 1956-03-22 1957-08-08 Schering Ag Verfahren zur Einfuehrung der Reste wenig reaktionsfaehiger Carbonsaeuren, insbesondere des ª‰-Cyclopentyl-propionylrestes, in die 17ª‡-staendige Oxygruppe solcher Steroide, die am Kohlenstoffatom 17 neben der Oxygruppe eine Acetylgruppe tragen
GB8313921D0 (en) 1983-05-19 1983-06-22 World Health Org Contraceptive compositions
DE4227989A1 (de) 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
DE4240806A1 (de) 1992-12-01 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 14alpha,17alpha-Ethanoestra-1,3,5(10)-trien-3,17beta-diol
JPH07101884A (ja) 1993-10-01 1995-04-18 Sanei Gen F F I Inc 水溶性ヘミセルロースを含有する製剤
AU692504B2 (en) * 1993-12-27 1998-06-11 Akzo Nobel N.V. Percutaneously absorbable preparation
JPH11509222A (ja) * 1995-07-17 1999-08-17 シェリング アクチェンゲゼルシャフト １３−エチル−１７β−ヒドロキシ−１１−メチレン−１８，１９−ジノル−１７α−プレグン−４−エン−２０−イン−３−オンのエステルを含む経皮投与のための剤
DE19613698A1 (de) 1995-07-17 1997-01-23 Schering Ag Mittel zur transdermalen Applikation enthaltend Ester des 13-Ethyl-17ß-hydroxy-11-methylen-18,19-dinor-17alpha-pregn-4-en-20-yn-3-ons
DE19531936A1 (de) * 1995-08-17 1997-02-20 Schering Ag Kombinationspräparat zur Kontrazeption, Kits diese enthaltend und eine Methode diese verwendend
DE19540253C2 (de) * 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
HUP0102274A3 (en) 1998-06-19 2002-08-28 Akzo Nobel Nv Testosterone derivative and pharmaceutical compositions containing the same
WO1999067270A1 (en) 1998-06-19 1999-12-29 Akzo Nobel N.V. Cycloalkyl-carboxylic acid esters of 7.alpha.methyl-estr-4-en-3-one 17.beta.-ol (19-nor 7.alpha.-methyltestosterone)
US6180682B1 (en) 1999-01-26 2001-01-30 Virgil A. Place Buccal drug delivery system for use in male contraception
TW200400041A (en) * 2002-05-30 2004-01-01 Akzo Nobel Nv Use of new etonogestrel esters

Also Published As

Publication number Publication date
RS97604A (sr) 2006-10-27
AU2003238081B2 (en) 2008-09-18
AR040130A1 (es) 2005-03-16
TW200403065A (en) 2004-03-01
RU2325910C2 (ru) 2008-06-10
BR0311254A (pt) 2005-03-15
EP1513861B1 (en) 2006-12-27
PE20040068A1 (es) 2004-02-18
PL373855A1 (en) 2005-09-19
CO5631449A2 (es) 2006-04-28
IL165087A0 (en) 2005-12-18
ATE349458T1 (de) 2007-01-15
ZA200410410B (en) 2006-02-22
MXPA04011797A (es) 2005-03-31
CA2487722C (en) 2011-07-19
DE60310714T2 (de) 2007-10-11
JP2005532350A (ja) 2005-10-27
HK1072609A1 (en) 2005-09-02
WO2003102012A9 (en) 2005-01-13
NZ536619A (en) 2007-09-28
AU2003238081A1 (en) 2003-12-19
US7323454B2 (en) 2008-01-29
CN101100480A (zh) 2008-01-09
CA2487722A1 (en) 2003-12-11
NO20044898L (no) 2005-02-25
DE60310714D1 (de) 2007-02-08
SI1513861T1 (sl) 2007-06-30
IS2421B (is) 2008-10-15
WO2003102012A2 (en) 2003-12-11
CN1314701C (zh) 2007-05-09
CN1692122A (zh) 2005-11-02
US20050222113A1 (en) 2005-10-06
JP4716726B2 (ja) 2011-07-06
PT1513861E (pt) 2007-03-30
UA80126C2 (en) 2007-08-27
DK1513861T3 (da) 2007-04-10
WO2003102012A3 (en) 2004-04-22
ES2277085T3 (es) 2007-07-01
HRP20041101A2 (en) 2004-12-31
RU2004138807A (ru) 2005-05-27
KR20050009723A (ko) 2005-01-25
EP1513861A2 (en) 2005-03-16

Similar Documents

Publication Publication Date Title
DE60328309D1 (de) Ssigkeiten
DE60332534D1 (de) Chinuclidinamidderivate
DE60325993D1 (de) Glyphlets
DE50310083D1 (de) Phthalocyaninpigmentzubereitungen
IS7528A (is) Nýir etónógestrel esterar
DE50310866D1 (de) Flanschverbindung
DE60330096D1 (de) Nadelabschirmanordnung
DE60330661D1 (de) Einführdichtungsanordnung
DE60218856D1 (de) Münzspeichermessung
DE60226008D1 (de) Sicherheitsgurtpresentiereinrichtung
DE60329596D1 (de) Währungsvalidierer
ATA1572002A (de) Managementspleisskassette
EP1560638A4 (en) TANGENTIAL FILTRATION HOUSING
FI5303U1 (fi) Ammesovitelma
DE50305973D1 (de) Auffangwanne
DE60321850D1 (de) Hochfrequenzfilterresonator
IS7537A (is) Notkun á nýjum etónógestrel esterum.
DE50214840D1 (de) Ethylestern
DE60304326D1 (de) Wärmeniet
ITMI20021327A1 (it) Nuove ossialchilpiperazine
FI20020958A0 (fi) Käsihihnasovitelma
NO20043433L (no) Fremgangsmate
DE60219966D1 (de) Virtuelles kegeln
SK3438U (sk) Redukčná ekoobjímka
FI20021839A0 (fi) Liitoslista